-
The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
Spencer K, Bindra R, Cacho AM, Nicolaides KH.
Prenat Diagn 2004;24:169-73. -
Umbilical cord diameter at 11-14 weeks of gestation: relation to chromosomal defects.
Rembouskos G, Cicero S, Papadopoulos V, Tripsanas C, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:237-9. -
Assessment of the fetal nasal bone at 11-14 weeks of gestation by three-dimensional ultrasound.
Rembouskos G, Cicero S, Longo D, Vandecruys H, Nicolaides KH.
Ultrasound Obstet Gynecol 2004;23:232-6. -
Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.
Nicolaides KH.
Am J Obstet Gynecol 2004;191:45-67. -
Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: A feasibility study.
Ng EK, El-Sheikhah A, Chiu RW, Chan KC, Hogg M, Bindra R, Leung TN, Lau TK, Nicolaides KH, Lo YM.
Clin Chem 2004;50:1055-7. -
Assessment of efficacy of cell separation techniques used in the enrichment of foetal erythroblasts from maternal blood: triple density gradient vs single density gradient.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Clin Lab Haematol 2004;26:123-8.